Prostatic Cancer Clinical Trials in Melbourne, Victoria
2 recruitingMelbourne, Victoria, Australia
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals130 enrolled50 locationsNCT07047118
Recruiting
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Breast CancerLiver CancerPancreatic Cancer+6 more
University of Sydney300 enrolled4 locationsNCT05184790